Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AC Immune (ACIU) Other Operating Expenses: 2014-2024

Historic Other Operating Expenses for AC Immune (ACIU) over the last 11 years, with Dec 2024 value amounting to $162,096.

  • AC Immune's Other Operating Expenses fell 208.31% to -$23,751 in Q3 2025 from the same period last year, while for Sep 2025 it was -$50,694, marking a year-over-year decrease of 109.30%. This contributed to the annual value of $162,096 for FY2024, which is 90.32% down from last year.
  • Latest data reveals that AC Immune reported Other Operating Expenses of $162,096 as of FY2024, which was down 90.32% from $1.7 million recorded in FY2023.
  • In the past 5 years, AC Immune's Other Operating Expenses ranged from a high of $1.7 million in FY2023 and a low of $162,096 during FY2024.
  • Its 3-year average for Other Operating Expenses is $1.1 million, with a median of $1.4 million in 2022.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first spiked by 159.87% in 2020, then slumped by 90.32% in 2024.
  • Over the past 5 years, AC Immune's Other Operating Expenses (Yearly) stood at $1.5 million in 2020, then decreased by 13.57% to $1.3 million in 2021, then climbed by 7.77% to $1.4 million in 2022, then rose by 20.17% to $1.7 million in 2023, then plummeted by 90.32% to $162,096 in 2024.